Abbott India Ltd

Abbott India announced that Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy, has tendered her resignation from employment of the Company with effect from the close of business hours of 15 April 2025, to pursue opportunities outside the Company. Pursuant to her resignation, she will also cease to be the Senior Management Personnel of the Company effective the said date. Powered by Capital Market - Live

Abbott India Ltd is down for a fifth straight session today. The stock is quoting at Rs 27903.95, down 1.6% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.87% on the day, quoting at 22830.85. The Sensex is at 75660.79, down 0.63%.Abbott India Ltd has added around 0.57% in last one month.Meanwhile, Nifty Pharma index of which Abbott India Ltd is a constituent, has eased around 5.47% in last one month and is currently quoting at 21427.1, down 3.06% on the day. The volume in the stock stood at 6806 shares today, compared to the daily average of 17286 shares in last one month. The benchmark February futures contract for the stock is quoting at Rs 27990.95, down 1.42% on the day. Abbott India Ltd tumbled 4.39% in last one year as compared to a 4.2% rally in NIFTY and a 11.87% spurt in the Nifty Pharma index.The PE of the stock is 45.18 based on TTM earnings ending December 24.Powered by Capital Market - Live

Abbott India Ltd is up for a fifth straight session today. The stock is quoting at Rs 29440, up 1.23% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.09% on the day, quoting at 23583.2. The Sensex is at 77886.15, down 0.22%. Abbott India Ltd has slipped around 0.57% in last one month. Meanwhile, Nifty Pharma index of which Abbott India Ltd is a constituent, has slipped around 4.11% in last one month and is currently quoting at 22009.05, up 0.26% on the day. The volume in the stock stood at 18060 shares today, compared to the daily average of 16001 shares in last one month. The benchmark February futures contract for the stock is quoting at Rs 29578.45, up 1.16% on the day. Abbott India Ltd is up 4.18% in last one year as compared to a 8.59% jump in NIFTY and a 19.15% jump in the Nifty Pharma index.The PE of the stock is 46.34 based on TTM earnings ending December 24.Powered by Capital Market - Live

Revenue from operations grew by 12.32% to Rs 1,614.28 crore in the quarter ended 31 December 2024. Profit before tax stood at Rs 487.59 crore in the third quarter of FY25, up 15.49% from Rs 422.16 crore posted in the same period a year ago. On nine-month basis, the pharma company's net profit grew 14.57% to Rs 1,047.40 crore on 8.94% rise in revenue from operations to Rs 4,804.56 crore in 9M FY24 over 9M FY23. Abbott India has a portfolio of science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. Powered by Capital Market - Live

Net profit of Abbott India rose 16.01% to Rs 360.78 crore in the quarter ended December 2024 as against Rs 310.98 crore during the previous quarter ended December 2023. Sales rose 12.33% to Rs 1614.28 crore in the quarter ended December 2024 as against Rs 1437.14 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1614.281437.14 12 OPM %27.0126.98 - PBDT505.58440.13 15 PBT487.59422.16 15 NP360.78310.98 16 Powered by Capital Market - Live

The Board of Abbott India at its meeting held on 05 February 2025 has appointed Harshraj Madan as Commercial Director ' GI Business effective 17 February 2025. He will be part of the Senior Management team of the Company.Powered by Capital Market - Live

Abbott India will hold a meeting of the Board of Directors of the Company on 5 February 2025.Powered by Capital Market - Live

Abbott India Ltd is down for a fifth straight session today. The stock is quoting at Rs 27173.55, down 2.06% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.45% on the day, quoting at 23317.15. The Sensex is at 77055.9, up 0.43%.Abbott India Ltd has lost around 2.94% in last one month.Meanwhile, Nifty Pharma index of which Abbott India Ltd is a constituent, has eased around 1.06% in last one month and is currently quoting at 21972.7, down 0.6% on the day. The volume in the stock stood at 8134 shares today, compared to the daily average of 12059 shares in last one month. The benchmark January futures contract for the stock is quoting at Rs 27194.15, down 2.15% on the day. Abbott India Ltd jumped 5.61% in last one year as compared to a 8.09% rally in NIFTY and a 27.33% spurt in the Nifty Pharma index.The PE of the stock is 45.92 based on TTM earnings ending September 24.Powered by Capital Market - Live

Abbott India has appointed Prithwish Kumar Banerji as Commercial Director - Women's Health, Metabolics and International Business with effect from 03 January 2025.Powered by Capital Market - Live

Abbott India announced that Murari Ranganathan, Commercial Director - Women's Health, Metabolics and International Business, has tendered his resignation from employment of the Company with effect from close of business hours of 25 February 2025. Powered by Capital Market - Live